Difference between revisions of "Part:BBa K1632000:Design"
JunKawamura (Talk | contribs) |
JunKawamura (Talk | contribs) |
||
Line 1: | Line 1: | ||
− | + | __NOTOC__ | |
<partinfo>BBa_K1632000 short</partinfo> | <partinfo>BBa_K1632000 short</partinfo> | ||
Line 13: | Line 13: | ||
====Invertion assay with FimB==== | ====Invertion assay with FimB==== | ||
− | + | =====1. Construction===== | |
All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.<br> | All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.<br> | ||
− | (1) PBAD/araC_fimB (pSB6A1) + ''fim'' switch[default ON](Tokyo_Tech/J23119) | + | (1) PBAD/araC_fimB(wild-type) (pSB6A1) + ''fim'' switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3) <br> |
− | (2) PBAD/araC_fimB (pSB6A1) + ''fim'' switch[default OFF](Tokyo_Tech/J23119) | + | (2) PBAD/araC_fimB(wild-type) (pSB6A1) + ''fim'' switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3) <br> |
− | (3) pSB6A1 + ''fim'' switch[default ON](Tokyo_Tech/J23119) | + | (3) pSB6A1 + ''fim'' switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3) …positive control 1<br> |
− | (4) pSB6A1 + ''fim'' switch[default OFF](Tokyo_Tech/J23119) | + | (4) pSB6A1 + ''fim'' switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3) …negative control 1<br> |
− | (5) PBAD/araC_fimB (pSB6A1) + | + | (5) PBAD/araC_fimB(wild-type) (pSB6A1) + J23119_gfp(pSB3K3) …positive control 2 <br> |
− | (6) PBAD/araC_fimB (pSB6A1) + rbs_gfp(pSB3K3) …negative control 2 <br> | + | (6) PBAD/araC_fimB(wild-type) (pSB6A1) + rbs_gfp(pSB3K3) …negative control 2 <br> |
− | + | =====2. Assay protocol===== | |
1. Prepare overnight cultures for the each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 0.5 %) at 37 ℃ for 12h.<br> | 1. Prepare overnight cultures for the each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 0.5 %) at 37 ℃ for 12h.<br> | ||
Line 43: | Line 43: | ||
<span style="margin-left: 20px;">※ As for C and D, the suspension were added only in medium ① and ④. <br> | <span style="margin-left: 20px;">※ As for C and D, the suspension were added only in medium ① and ④. <br> | ||
12. Incubate the samples at 37 ℃, shaking at 180 rpm for 6.5 hours. (Measure OD590 of all the samples every hour.)<br> | 12. Incubate the samples at 37 ℃, shaking at 180 rpm for 6.5 hours. (Measure OD590 of all the samples every hour.)<br> | ||
+ | 13. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.<br> | ||
+ | 14. Remove the supernatant.<br> | ||
+ | 15. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3)<br> | ||
+ | 16. Dispense all of each suspension into a disposable tube through a cell strainer.<br> | ||
+ | 17. Use flow cytometer to measure the fluorescence of GFP. (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company.)<br> | ||
+ | |||
+ | ====Invertion assay with FimE==== | ||
+ | |||
+ | =====1. Construction===== | ||
+ | |||
+ | All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.<br> | ||
+ | |||
+ | (1) PBAD/''araC''_fimE(wild-type) (pSB6A1) + ''fim'' switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3) <br> | ||
+ | (2) PBAD/''araC''_fimE(wild-type) (pSB6A1) + ''fim'' switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3) <br> | ||
+ | (3) pSB6A1 + ''fim'' switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3) …positive control 1<br> | ||
+ | (4) pSB6A1 + ''fim'' switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3) …negative control 1<br> | ||
+ | (5) PBAD/''araC''_fimE(wild-type) (pSB6A1) + J23119_gfp (pSB3K3) …positive control 2 <br> | ||
+ | (6) PBAD/''araC''_fimE(wild-type) (pSB6A1) + rbs_gfp (pSB3K3) …negative control 2 <br> | ||
+ | |||
+ | =====2. Assay protocol===== | ||
+ | |||
+ | 1. Prepare overnight cultures for the each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 1.0 %) at 37 ℃ for 12h.<br> | ||
+ | 2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp, Kan and glucose (final concentration of mass of glucose is 1.0 %).<br> | ||
+ | 3.Grow the cells at 37 ℃, shaking at 180 rpm until the observed OD590 reaches 0.4 (Fresh Culture).<br> | ||
+ | 4. After incubation, take 1 mL of the samples, and centrifuge at 5000x g, 1 min, 25 ℃ <br> | ||
+ | 5. Remove the supernatant.<br> | ||
+ | 6. Add 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃ <br> | ||
+ | 7. Remove the supernatant.<br> | ||
+ | 8. Take the samples, and centrifuge at 5000x g, 1 min, 25 ℃ <br> | ||
+ | 9. Remove the supernatant.<br> | ||
+ | 10. Suspend the pellet in 1mL of LB containing Amp and Kan.<br> | ||
+ | 11. Add 30 microL of suspension in the following medium.<br> | ||
+ | <span style="margin-left: 20px;">① 3 mL of LB containing Amp, Kan and 30 microL of sterile water<br> | ||
+ | <span style="margin-left: 20px;">② 3 mL of LB containing Amp, Kan and 30 microL of 500 microM arabinose (final concentration of arabinose is 5 microM)<br> | ||
+ | <span style="margin-left: 20px;">③ 3 mL of LB containing Amp, Kan and 30 microL of 1 mM arabinose (final concentration of arabinose is 10 microM)<br> | ||
+ | <span style="margin-left: 20px;">④ 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)<br> | ||
+ | <span style="margin-left: 20px;">※ As for C and D, the suspension were added only in medium ① and ④. <br> | ||
+ | 12. Incubate the samples at 37 ℃ for 6 hours, shaking at 180 rpm. (Measure the OD590 of all the samples every hour.)<br> | ||
13. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.<br> | 13. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.<br> | ||
14. Remove the supernatant.<br> | 14. Remove the supernatant.<br> |
Revision as of 14:39, 17 September 2015
fim switch[deault ON](Tokyo_Tech/J23119)
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 345
Illegal NheI site found at 368 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 374
Illegal BamHI site found at 333 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
sequence confirmed
Materials and Methods
Invertion assay with FimB
1. Construction
All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.
(1) PBAD/araC_fimB(wild-type) (pSB6A1) + fim switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3)
(2) PBAD/araC_fimB(wild-type) (pSB6A1) + fim switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3)
(3) pSB6A1 + fim switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3) …positive control 1
(4) pSB6A1 + fim switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3) …negative control 1
(5) PBAD/araC_fimB(wild-type) (pSB6A1) + J23119_gfp(pSB3K3) …positive control 2
(6) PBAD/araC_fimB(wild-type) (pSB6A1) + rbs_gfp(pSB3K3) …negative control 2
2. Assay protocol
1. Prepare overnight cultures for the each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 0.5 %) at 37 ℃ for 12h.
2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp, Kan and glucose (final concentration of mass of glucose is 0.5 %).
3.Grow the cells at 37 ℃, shaking at 180 rpm until the observed OD590 reaches 0.4 (Fresh Culture).
4. After incubation, take 1 mL of the samples, and centrifuge at 5000x g, 1 min, 25 ℃
5. Remove the supernatant.
6. Add 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
7. Remove the supernatant.
8. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
9. Remove the supernatant.
10. Add 1 mL of LB containing Amp and Kan, and suspend.
11. Add 30 microL of suspension in the following medium.
① 3 mL of LB containing Amp, Kan, glucose (final concentration of mass of glucose is 0.5 %) and 30 microL of sterile water
② 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)
③ 3 mL of LB containing Amp, Kan and 30 microL of 20 mM arabinose (final concentration of arabinose is 200 microM)
④ 3 mL of LB containing Amp, Kan and 30 microL of 500 mM arabinose (final concentration of arabinose is 5 mM)
※ As for C and D, the suspension were added only in medium ① and ④.
12. Incubate the samples at 37 ℃, shaking at 180 rpm for 6.5 hours. (Measure OD590 of all the samples every hour.)
13. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.
14. Remove the supernatant.
15. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3)
16. Dispense all of each suspension into a disposable tube through a cell strainer.
17. Use flow cytometer to measure the fluorescence of GFP. (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company.)
Invertion assay with FimE
1. Construction
All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.
(1) PBAD/araC_fimE(wild-type) (pSB6A1) + fim switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3)
(2) PBAD/araC_fimE(wild-type) (pSB6A1) + fim switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3)
(3) pSB6A1 + fim switch[default ON](Tokyo_Tech/J23119)_gfp (pSB3K3) …positive control 1
(4) pSB6A1 + fim switch[default OFF](Tokyo_Tech/J23119)_gfp (pSB3K3) …negative control 1
(5) PBAD/araC_fimE(wild-type) (pSB6A1) + J23119_gfp (pSB3K3) …positive control 2
(6) PBAD/araC_fimE(wild-type) (pSB6A1) + rbs_gfp (pSB3K3) …negative control 2
2. Assay protocol
1. Prepare overnight cultures for the each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 1.0 %) at 37 ℃ for 12h.
2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp, Kan and glucose (final concentration of mass of glucose is 1.0 %).
3.Grow the cells at 37 ℃, shaking at 180 rpm until the observed OD590 reaches 0.4 (Fresh Culture).
4. After incubation, take 1 mL of the samples, and centrifuge at 5000x g, 1 min, 25 ℃
5. Remove the supernatant.
6. Add 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
7. Remove the supernatant.
8. Take the samples, and centrifuge at 5000x g, 1 min, 25 ℃
9. Remove the supernatant.
10. Suspend the pellet in 1mL of LB containing Amp and Kan.
11. Add 30 microL of suspension in the following medium.
① 3 mL of LB containing Amp, Kan and 30 microL of sterile water
② 3 mL of LB containing Amp, Kan and 30 microL of 500 microM arabinose (final concentration of arabinose is 5 microM)
③ 3 mL of LB containing Amp, Kan and 30 microL of 1 mM arabinose (final concentration of arabinose is 10 microM)
④ 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)
※ As for C and D, the suspension were added only in medium ① and ④.
12. Incubate the samples at 37 ℃ for 6 hours, shaking at 180 rpm. (Measure the OD590 of all the samples every hour.)
13. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.
14. Remove the supernatant.
15. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3)
16. Dispense all of each suspension into a disposable tube through a cell strainer.
17. Use flow cytometer to measure the fluorescence of GFP. (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company.)
Source
Gene synthesis by eurofins
References
Ian C. Blomfield et al. (1997) Integration host factor stimulates both FimB- andFimE-mediated site-specific DNA inversion that controlsphase variation of type 1 fimbriae expression in Escherichia coli. Molecular Microbiology 23(4), 705–717
John M. Abraham et al. (1985) An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A 82(17):5724-7
Matthew P. McCusker et al. (2008) DNA sequence heterogeneity in Fim tyrosine-integrase recombinase-binding elements and functional motif asymmetries determine the directionality of the fim genetic switch in Escherichia coli K-12. Molecular Microbiology 67(1): 171–187